Literature DB >> 18590692

Dynamic functional relay between insulin receptor substrate 1 and 2 in hepatic insulin signaling during fasting and feeding.

Naoto Kubota1, Tetsuya Kubota, Shinsuke Itoh, Hiroki Kumagai, Hideki Kozono, Iseki Takamoto, Tomoka Mineyama, Hitomi Ogata, Kumpei Tokuyama, Mitsuru Ohsugi, Takayoshi Sasako, Masao Moroi, Kaoru Sugi, Shigeru Kakuta, Yoichiro Iwakura, Tetsuo Noda, Shin Ohnishi, Ryozo Nagai, Kazuyuki Tobe, Yasuo Terauchi, Kohjiro Ueki, Takashi Kadowaki.   

Abstract

Insulin receptor substrate (Irs) mediates metabolic actions of insulin. Here, we show that hepatic Irs1 and Irs2 function in a distinct manner in the regulation of glucose homeostasis. The PI3K activity associated with Irs2 began to increase during fasting, reached its peak immediately after refeeding, and decreased rapidly thereafter. By contrast, the PI3K activity associated with Irs1 began to increase a few hours after refeeding and reached its peak thereafter. The data indicate that Irs2 mainly functions during fasting and immediately after refeeding, and Irs1 functions primarily after refeeding. In fact, liver-specific Irs1-knockout mice failed to exhibit insulin resistance during fasting, but showed insulin resistance after refeeding; conversely, liver-specific Irs2-knockout mice displayed insulin resistance during fasting but not after refeeding. We propose the concept of the existence of a dynamic relay between Irs1 and Irs2 in hepatic insulin signaling during fasting and feeding.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18590692     DOI: 10.1016/j.cmet.2008.05.007

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  86 in total

1.  Hepatic suppression of Foxo1 and Foxo3 causes hypoglycemia and hyperlipidemia in mice.

Authors:  Kebin Zhang; Ling Li; Yajuan Qi; Xiaoping Zhu; Boyi Gan; Ronald A DePinho; Travis Averitt; Shaodong Guo
Journal:  Endocrinology       Date:  2011-12-06       Impact factor: 4.736

2.  Development of novel cell lines of diabetic dysfunction model fit for cell-based screening tests of medicinal materials.

Authors:  Mikako Saito; Aya Hayakawa; Nobuya Inagaki; Hideaki Matsuoka
Journal:  Cytotechnology       Date:  2012-07-10       Impact factor: 2.058

Review 3.  The role of FOXO in the regulation of metabolism.

Authors:  Danielle N Gross; Min Wan; Morris J Birnbaum
Journal:  Curr Diab Rep       Date:  2009-06       Impact factor: 4.810

4.  Hoofbeats, zebras, and insights into insulin resistance.

Authors:  Robert A Hegele; Karen Reue
Journal:  J Clin Invest       Date:  2009-02       Impact factor: 14.808

Review 5.  Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms.

Authors:  Shaodong Guo
Journal:  J Endocrinol       Date:  2014-01-08       Impact factor: 4.286

6.  Fibroblast growth factor-19, a novel factor that inhibits hepatic fatty acid synthesis.

Authors:  Sushant Bhatnagar; Holly A Damron; F Bradley Hillgartner
Journal:  J Biol Chem       Date:  2009-02-20       Impact factor: 5.157

7.  Distinct signalling properties of insulin receptor substrate (IRS)-1 and IRS-2 in mediating insulin/IGF-1 action.

Authors:  Atefeh Rabiee; Marcus Krüger; Jacob Ardenkjær-Larsen; C Ronald Kahn; Brice Emanuelli
Journal:  Cell Signal       Date:  2018-03-14       Impact factor: 4.315

8.  Selective regulation of heme oxygenase-1 expression and function by insulin through IRS1/phosphoinositide 3-kinase/Akt-2 pathway.

Authors:  Pedro Geraldes; Kunimasa Yagi; Yuzuru Ohshiro; Zhiheng He; Yasuhiro Maeno; Junko Yamamoto-Hiraoka; Christian Rask-Madsen; Su Wol Chung; Mark A Perrella; George L King
Journal:  J Biol Chem       Date:  2008-10-14       Impact factor: 5.157

9.  Foxo1 integrates insulin signaling with mitochondrial function in the liver.

Authors:  Zhiyong Cheng; Shaodong Guo; Kyle Copps; Xiaochen Dong; Ramya Kollipara; Joseph T Rodgers; Ronald A Depinho; Pere Puigserver; Morris F White
Journal:  Nat Med       Date:  2009-10-18       Impact factor: 53.440

10.  Phosphorylation of serine 1137/1138 of mouse insulin receptor substrate (IRS) 2 regulates cAMP-dependent binding to 14-3-3 proteins and IRS2 protein degradation.

Authors:  Sabine S Neukamm; Jennifer Ott; Sascha Dammeier; Rainer Lehmann; Hans-Ulrich Häring; Erwin Schleicher; Cora Weigert
Journal:  J Biol Chem       Date:  2013-04-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.